With support from Sheikha Fatima, UAE to restore Umayyad Mosque in Damascus
Mother of the Nation Endowment for Orphans’ initiative raises AED3.3bn during Ramadan; launches AED1 bn ‘Mother of the Nation City’ project
UAE sends 30 tonnes of food aid to support drought-affected communities in Kenya
UAE provides urgent relief to support flood-affected communities in Mozambique
Amman, May 21 (Petra) – The Jordan Food and Drug Administration
(JFDA) participated in the fourth meeting of the International Expert
Group on Expanding the International Narcotics Control Board’s (INCB)
Lists of Hazardous Substances with Unknown Uses, held at United
Nations headquarters in Vienna.
According to a JFDA statement issued Thursday, Head of the Narcotics,
Psychotropic Substances, and Chemical Precursors Department Malak
Mahayreh took part alongside international experts in discussions on
advanced methods for identifying hazardous substances found in
counterfeit or illegally manufactured pharmaceutical products.
During the meeting, Mahayreh delivered a presentation titled “The
Regulatory Framework in Jordan and the Latest Developments Related to
the Scheduling of Narcotics, Psychotropic Substances, and Chemical
Precursors.”
She reviewed Jordan’s regulatory framework governing the scheduling
of controlled substances, highlighted comparisons between Jordanian
and international classification systems, and outlined the substances
added to national schedules over the past five years.
Participants and international experts commended Jordan’s experience
in the field, particularly its advanced monitoring systems and
regulatory mechanisms, highlighting the Kingdom’s regional standing
in combating narcotic and psychotropic substances.
The participation also included coordination with the Anti-Narcotics
Department in drafting the meeting’s final recommendations, including
calls for relevant authorities to engage in international operations
aimed at reporting newly emerging substances and counterfeit
pharmaceutical products, as well as adopting modern approved tracking
systems for such materials.
Director General of the JFDA Rana Obeidat said the participation
reflects the institution’s active international role and the
expertise of its specialized personnel, contributing to showcasing
the strength of Jordan’s regulatory framework and reinforcing the
JFDA’s position as a trusted reference authority in pharmaceutical
regulation.
//Petra// AJ